Cardinal Health Inc. recalls

All Cardinal Health Inc. recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (5).

5 recalls published between May 7, 2025 and September 3, 2025. Most common issues: manufacturing practices (cgmp) (3).

• Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL… recall
  FDA September 3, 2025 · Cardinal Health Inc. · Class II
• RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only… recall
  FDA August 13, 2025 · Cardinal Health Inc. · Class II
• Xolair (omalizumab injection), 75 mg/0.5 ml, Rx only, Genentech, Inc… recall
  FDA August 13, 2025 · Cardinal Health Inc. · Class II
• Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only… recall
  FDA August 13, 2025 · Cardinal Health Inc. · Class II
• Wegovy (semaglutide) injection, 2.4 mg/0.75 mL… recall
  FDA May 7, 2025 · Cardinal Health Inc. · Class II